Vitamin D metabolism and vitamin D traditional and nontraditional, target organs: Implications for kidney patients

Journal of Renal Care

Volumn 35, Issue SUPPL. 1, 2009, Pages 39-44

  Dusilová Sulková, Sylvie ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Calcitriol; Chronic kidney disease; Paricalcitol; Selective vitamin D receptor activation; Syndrome of vitamin D deficiency; Vitamin D; Vitamin D receptor

Indexed keywords

CALCITRIOL RECEPTOR; VITAMIN; VITAMIN D;

ARTICLE; CHRONIC KIDNEY FAILURE; DIAGNOSTIC ERROR; DRUG EFFECT; HOSPITALIZATION; HUMAN; METABOLISM; METHODOLOGY; NEPHROLOGY; NUTRITIONAL ASSESSMENT; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PHYSIOLOGY; RENAL OSTEODYSTROPHY; RISK FACTOR; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

DIAGNOSTIC ERRORS; HUMANS; KIDNEY FAILURE, CHRONIC; NEPHROLOGY; NUTRITION ASSESSMENT; PATIENT CARE TEAM; RECEPTORS, CALCITRIOL; RENAL OSTEODYSTROPHY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 61649088836     PISSN: 17556678     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2009.00066.x     Document Type: Article

References (12)

1. Andress D.L. (2006). Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney International 69, 33-43.
2. Autier P. & Gandini S. (2007). Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Archives of Internal Medicine 10, 1730-1737.
3. Dusso A.S., Brown A.J. & Slatopolsky E. (2005). Vitamin D. American Journal of Physiology Renal Physiology 289, F8-F28.
4. Hollick M. (2007). Vitamin D deficiency. The New England Journal of Medicine 357, 266-281.
5. Kovesdy C.P. & Kalantar-Zadeh K. (2008). Vitamin D receptor activation and survival in chronic kidney disease. Kidney International 73, 1355-1363.
6. London G.M., Guerin A.P., Verbeke F.H. et al. (2007). Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. Journal of the American Society of Nephrology 18, 613-620.
7. Seibert E., Lewin N.W. & Kuhlmann M.K. (2005). Immunomodulationg effects of vitamin D analogs in hemodialysis patients. Hemodialysis international 9, S25-S29.
8. Slatopolsky E., Weerts C., Thielan J. et al. (1984). Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25 dihydroxycholecalciferol in uremic patients. The Journal of Clinical Investigation 74, 2136-2143.
9. Taskapan H. & Wei M. (2006). 25(OH) vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance. International Urology and Nephrology 38, 323-329.
10. Teng M., Wolf M., Ofsthun N. et al. (2006). Activated injectable vitamin D and hemodialysis survival: a historical cohort study. Journal of the American Society of Nephrology 16, 1115-1125.
11. Tian J., Liu Y, Williams L. et al. (2007). Potential role of active vitamin D in retarding the progression of chronic kidney disease. Nephrology, Dialysis, transplantation 22, 321-328.
12. Wolisi G.O. & Moe S.M. (2005). The role of vitamin D in vascular calcification in chronic kidney disease. Seminars in Dialysis 18, 307-314.